greeksoup/ stock research
Stock research / United States / BBIO / 13F holders

BridgeBio Pharma, Inc. 13F holders

476 funds reported a position in BridgeBio Pharma, Inc. in their 13F for the quarter ended 30 June 2026, together 193.7 million shares worth $14.42 billion. Against the quarter before, 68 opened a position, 169 added, 166 trimmed and 69 sold out; together they sold a net 3.6 million shares. The largest holders: Jupiter Topco LLC, Kohlberg Kravis Roberts & Co. L.P. and Farallon Capital Management, L.l.c.

Funds holding476+12 on Q1 2026
Shares they held193.7Mworth $14.42 billion
Net sold on the quarter3.6M sharesabout $269.0 million at the funds' values
Funds buying to selling237 to 235opened or added, to cut or sold
Opened 68Added 169Held 68Trimmed 166Sold out 69
Opened: 68 fundsAdded: 169 fundsHeld: 68 fundsTrimmed: 166 fundsSold out: 69 funds

What each fund did in BBIO against its 13F for the quarter before; a change under 0.1% of a holding counts as held

Q3 2024: 254 funds, 174.0 million shares254Q3 2024Q4 2024: 263 funds, 176.7 million shares263Q4 2024Q1 2025: 304 funds, 186.5 million shares304Q1 2025Q2 2025: 359 funds, 189.0 million shares359Q2 2025Q3 2025: 393 funds, 185.4 million shares393Q3 2025Q4 2025: 436 funds, 191.6 million shares436Q4 2025Q1 2026: 464 funds, 194.7 million shares464Q1 2026Q2 2026: 476 funds, 193.7 million shares476Q2 2026

Funds reporting a position in BBIO in their 13F, each quarter; hover a bar for the shares they held

Filed so far for the quarter to 30 September 2026

2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 66 reported a position in BridgeBio Pharma, Inc.: 10 opened one, 19 added, 19 trimmed and 9 sold out, a net 80,353 shares sold.

FundChange in sharesShares nowStatusFiling
Y-Intercept (Hong Kong) Ltd-91,71015,709trimmed13F
Tema Etfs LLC+22,65398,729added13F
Burney Co.+21,14621,146new13F
Assenagon Asset Management S.A.-16,79614,444trimmed13F
Assetmark, Inc.+6,58430,640added13F
Total Clarity Wealth Management, Inc.-6,4244,998trimmed13F
HB Wealth Management, LLC+3,5133,513new13F
Atria Investments, Inc+3,0583,058new13F
Nisa Investment Advisors, LLC-1,9574,720trimmed13F
Abel Hall, LLC-1,7584,861trimmed13F
Wealth Enhancement Advisory Services, LLC-1,42111,781trimmed13F
IFP Advisors, Inc+1,1842,344added13F
LVW Advisors, LLC-1,0963,237trimmed13F
Inspire Investing, LLC+88711,160added13F
Park Avenue Securities LLC+8095,170added13F
Sterling Capital Management LLC-704631trimmed13F
Harbor Investment Advisory, LLC-5361,299trimmed13F
DMC Group, LLC+5173,517added13F
Central Pacific Bank - Trust Division-4937,274trimmed13F
Gamma Investing LLC+3742,020added13F
GF Fund Management Co. Ltd+3654,468added13F
Vontobel Holding Ltd.-23935,124trimmed13F
Farther Finance Advisors, LLC-1811,062trimmed13F
SBI Securities Co., Ltd.+157441added13F
Contravisory Investment Management, Inc.-144144trimmed13F

The largest moves in the name among the funds that have filed, against each fund's previous 13F.

The well-known funds

Of the 44 funds followed here, 11 reported a position in BridgeBio Pharma, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Viking Global Investors, 9.9 million shares worth $741.0 million, 2.1% of its reported book. New this quarter: Point72 Asset Management. In the quarter, 5 funds added or opened a position and 5 trimmed or sold out; together they bought a net 508,625 shares, about $37.9 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
Viking Global Investors9,949,219$741.0 million2.1%-1,893,215trimmed30 June 202613F
Two Sigma Investments4,722,185$351.7 million0.3%+1,601,554added30 June 202613F
Citadel Advisors3,760,028$280.0 million0.2%+586,088added30 June 202613F
Geode Capital Management3,418,419$254.7 million0.0%-1,499,611trimmed30 June 202613F
FMR LLC2,061,307$153.5 million0.0%-282,447trimmed30 June 202613F
Norges Bank1,693,773$126.2 million0.0%held30 June 202613F
Point72 Asset Management1,525,782$113.6 million0.2%+1,525,782new30 June 202613F
Renaissance Technologies856,846$63.8 million0.1%+491,074added30 June 202613F
Capital Research Global Investors700,107$52.1 million0.0%-63,595trimmed30 June 202613F
Millennium Management487,594$36.3 million0.0%-145,689trimmed30 June 202613F
Bridgewater Associates448,143$33.4 million0.1%+188,684added30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

The largest holders

FundSharesShare of allValueOf its bookChange in sharesFiling
Jupiter Topco LLC14,110,2787.28%$1.05 billion0.43%first 13F13F
Kohlberg Kravis Roberts & Co. L.P.13,260,9716.85%$987.7 million18.08%no change13F
Farallon Capital Management, L.l.c.10,743,0635.55%$800.1 million4.72%+1,377,60013F
BlackRock, Inc.10,287,1565.31%$766.2 million0.01%-3,920,60113F
Viking Global Investors LP9,949,2195.14%$741.0 million2.11%-1,893,21513F
Vanguard Capital Management LLC7,898,9734.08%$588.3 million0.01%+139,47813F
Vanguard Portfolio Management LLC7,656,7223.95%$570.3 million0.03%-423,85113F
Wellington Management Group LLP5,308,9242.74%$395.4 million0.07%+2,824,97113F
Two Sigma Investments, LP4,722,1852.44%$351.7 million0.27%+1,601,55413F
Aisling Capital Management LP4,589,6112.37%$341.8 million72.48%-500,00013F
State Street Corp.4,435,9322.29%$330.4 million0.01%-498,38813F
Citadel Advisors LLC3,760,0281.94%$280.0 million0.16%+586,08813F
Invesco Ltd.3,700,9341.91%$275.6 million0.02%-891,88013F
D. E. Shaw & Co., Inc.3,633,0071.88%$270.6 million0.18%+1,087,52113F
Geode Capital Management, LLC3,418,4191.76%$254.7 million0.01%-1,499,61113F
Jane Street Group, LLC2,934,1931.51%$218.5 million0.14%+1,176,52113F
JPMorgan Chase & Co.2,397,9951.24%$173.2 million0.01%+1,085,73613F
Adage Capital Partners GP, L.l.c.2,252,0001.16%$167.7 million0.23%+1,653,00013F
Franklin Resources Inc.2,160,1731.12%$160.9 million0.04%-278,75213F
Polar Capital Holdings Plc2,063,6091.07%$153.7 million0.44%-455,69713F
FMR LLC2,061,3071.06%$153.5 million0.01%-282,44713F
Manufacturers Life Insurance Company, the1,955,7331.01%$145.7 million0.11%-21,34713F
SC US (ttgp), Ltd1,860,3640.96%$138.6 million0.43%no change13F
Goldman Sachs Group Inc.1,814,6570.94%$135.2 million0.01%-83,05913F
UBS Group AG1,757,1520.91%$130.9 million0.02%-269,66913F
Price T Rowe Associates Inc.1,726,3830.89%$128.6 million0.01%-2,075,27213F
Charles Schwab Investment Management Inc.1,709,4170.88%$127.3 million0.02%-266,67713F
Norges Bank1,693,7730.87%$126.2 million0.01%13F
Morgan Stanley1,693,6520.87%$126.1 million0.01%-183,70713F
Ameriprise Financial Inc.1,551,6630.80%$115.6 million0.02%+303,14213F
Frazier Life Sciences Management, L.P.1,548,1390.80%$115.3 million2.51%-1,900,00013F
Point72 Asset Management, L.P.1,525,7820.79%$113.6 million0.18%new13F
AllianceBernstein L.P.1,453,5040.75%$107.9 million0.04%-455,40313F
Pictet Asset Management Holding SA1,448,1260.75%$107.4 million0.10%+66,94213F
Frontier Capital Management Co. LLC1,373,0570.71%$102.3 million0.95%+415,06813F
Laurion Capital Management LP1,352,2340.70%$100.7 million7.60%+89,58313F
Hood River Capital Management LLC1,347,5350.70%$100.4 million0.73%+82,45513F
Bank of America Corp.1,235,3800.64%$92.0 million0.01%-50,36813F
Balyasny Asset Management L.P.1,230,0520.64%$91.6 million0.17%+879,95613F
Squarepoint Ops LLC1,191,7320.62%$88.8 million0.17%+635,40813F
Bellevue Group AG1,189,5060.61%$88.6 million1.86%+1,164,12913F
BNP Paribas Financial Markets1,155,4420.60%$86.1 million0.04%-151,73413F
GW&K Investment Management, LLC1,125,1310.58%$83.8 million0.66%+162,48813F
Vanguard Fiduciary Trust Co.1,116,9890.58%$83.2 million0.02%-58,14613F
HRT Financial LP1,089,3760.56%$81.1 million0.15%+1,017,51113F
Principal Financial Group Inc.1,024,4230.53%$76.3 million0.04%-305,99213F
Primecap Management Co.1,015,9800.52%$75.7 million0.04%+446,80013F
FIL Ltd1,002,2600.52%$74.6 million0.05%+1,002,17213F
Clearbridge Investments, LLC993,1030.51%$74.0 million0.06%+41,90313F
Northern Trust Corp.959,5130.50%$71.5 million0.01%-444,12913F
The 50 largest of the 476 funds that reported a position in BBIO in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read moreShare of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?

Options the funds reported on BBIO

FundOptionShares under the optionsValue of those sharesQuarter endedFiling
Citadel AdvisorsCalls285,700$21.3 million30 June 202613F
Citadel AdvisorsPuts281,200$20.9 million30 June 202613F
Millennium ManagementCalls182,200$13.6 million30 June 202613F
Two Sigma InvestmentsPuts13,100$975,68830 June 202613F
Two Sigma InvestmentsCalls10,000$744,80030 June 202613F
Point72 Asset ManagementCalls7,000$521,36030 June 202613F
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read moreThey are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
27 October 202613GBlackRock, Inc. and 1 other9.9 million5.1%30 September 2026passive, institutional (13d-1(b))EDGAR
17 August 202613D/AKKR Genetic Disorder L.P. and 8 others9.2 million4.7%13 August 2026Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Sale of Common Stock On August 13, 2026, KKR Genetic Disorder L.P., as a selling stockholder, and the Issuer entered into an underwriting agreement (the ''UnderwritinEDGAR
3 August 202613G/AFarallon Capital Management, L.L.C. and 57 others10.7 million5.5%30 June 2026passive, institutional (13d-1(b))EDGAR
27 July 202613G/ABlackRock, Inc. and 1 other9.7 million5.0%30 June 2026passive, institutional (13d-1(b))EDGAR
10 July 202613D/AViking Global Investors LP and 6 others9.8 million5.0%9 July 2026Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 5(c) of this Amendment No. 12 is incorporated by reference herein.EDGAR
29 May 202613GFarallon Capital Partners, L.P. and 55 others10.2 million5.2%22 May 2026passive, under 20% (13d-1(c))EDGAR
15 May 202613G/AJanus Henderson Group PLC and 1 other13.2 million6.8%31 March 2026passive, institutional (13d-1(b))EDGAR
16 April 202613G/ANeil Kumar and 1 other9.3 million4.6%31 March 2026passive, other (13d-1(d))EDGAR
2 April 202613D/AViking Global Investors LP and 6 others11.8 million6.1%31 March 2026Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 5(c) of this Amendment No. 11 is incorporated by reference herein.EDGAR
26 March 202613G/AThe Vanguard Group and 1 other00.0%13 March 2026passive, institutional (13d-1(b))EDGAR
17 February 202613GJanus Henderson Group PLC and 1 other11.0 million5.7%31 December 2025passive, institutional (13d-1(b))EDGAR
17 February 202613D/AViking Global Investors LP and 7 others13.0 million6.8%12 February 2026Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 5(c) of this Amendment No. 10 is incorporated by reference herein.EDGAR
14 November 202513D/AViking Global Investors LP and 13 others15.9 million8.2%14 November 2025Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 5(c) of this Amendment No. 9 is incorporated by reference herein.EDGAR
14 November 202513GT. Rowe Price Associates, Inc. and 1 other885,0421.1%30 September 2025passive, institutional (13d-1(b))EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13G

Fails to deliver

Settlement dateShares failedPriceFile
18 September 20265,445$67.31SEC
14 September 202650,173$72.44SEC
11 September 2026105$72.50SEC
10 September 2026283$76.08SEC
8 September 20262$74.84SEC
4 September 2026123$75.41SEC
2 September 20264,996$76.57SEC
25 August 202657$81.07SEC
24 August 202635$81.50SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 50,173 on 14 September 2026. A fail is an operational fact about settlement, not a position.